Discover 1,830 paid clinical trials in Dallas, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Moderna
Location:
Code:
NCT05575492
Conditions
Cytomegalovirus
Eligibility Criteria
Sex: All
Age: 9 - 15
Healthy Volunteers: Accepted
Interventions
mRNA-1647
Placebo
Sponsor:
AstraZeneca
Location:
Code:
NCT06307665
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
BDA MDI
AS MDI
Sponsor:
NRG Oncology
Location:
Code:
NCT05095376
Conditions
Glioblastoma
Gliosarcoma
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Lomustine
Magnetic Resonance Imaging
Photon Beam Radiation Therapy
Questionnaire Administration
Temozolomide
Sponsor:
Bristol-Myers Squibb
Location:
Code:
NCT05552976
Conditions
Relapsed or Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Mezigdomide
Carfilzomib
Dexamethasone
Sponsor:
Idorsia Pharmaceuticals Ltd.
Location:
Code:
NCT05672576
Conditions
Lupus Erythematosus, Systemic
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Cenerimod
Placebo
Sponsor:
AbbVie
Location:
Code:
NCT05711394
Conditions
Episodic Migraine
Eligibility Criteria
Sex: All
Age: 6 - 17
Healthy Volunteers: Not accepted
Interventions
Atogepant
Placebo-Matching Atogepant
Sponsor:
Allogene Therapeutics
Location:
Code:
NCT06500273
Conditions
Large B-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cemacabtagene ansegedleucel
ALLO-647
Fludarabine
Cyclophosphamide
Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
Sponsor:
Intec Pharma Ltd.
Location:
Code:
NCT02615873
Conditions
Parkinson's Disease
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
Accordion Pill™ Carbidopa/Levodopa
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT03486873
Conditions
Solid Tumors
Hematologic Malignancies
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Standard of Care (SOC)
Lenvatinib
Olaparib
MK-4280
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT06291376
Conditions
Immunoglobulin A Nephropathy
IgAN
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ravulizumab
Placebo
Sponsor:
Exelixis
Location:
Code:
NCT05678673
Conditions
Non-Clear Cell Renal Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
XL092
Nivolumab
Sunitinib Malate
Sponsor:
EpicentRx, Inc.
Location:
Code:
NCT05966194
Conditions
Oral Mucositis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RRx-001
Intensity Modulated Radiation Therapy (IMRT)
Cisplatin for injection 100 mg/m2
Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.
These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.
Dallas offers distinct advantages for those considering participation in clinical trials. The city's growing health sciences industry and diverse population provides a wide range of participants, which improves the accuracy and applicability of research findings. Dallas is also renowned for its innovative research landscape, with a strong emphasis on medical advancements and groundbreaking studies.
In Dallas, clinical trials encompass a broad spectrum of medical conditions and diseases, underscoring the city’s role as a leading center for innovative research.
Cardiovascular clinical trials in Dallas address a variety of heart-related conditions, including coronary artery disease, heart failure, and hypertension. Research focuses on pioneering therapies such as new-generation stents, novel anticoagulants, and innovative heart failure treatments.
Medical device clinical trials are also commonly explored, like implantable cardioverter-defibrillators (ICDs) and ventricular assist devices (VADs), as well as lifestyle interventions and surgical techniques aimed at improving cardiovascular health and reducing the incidence of heart disease.
Dallas is at the forefront of cancer research, with trials investigating multiple types of malignancies including breast cancer, prostate cancer, lung cancer, and leukemia. Researchers are testing cutting-edge therapies such as CAR-T cell therapy, which involves engineering a patient’s own immune cells to target cancer, and new immune checkpoint inhibitors that boost the body’s ability to fight cancer.
Trials also focus on personalized medicine approaches, where treatments are tailored based on the genetic profile of both the patient and the tumor, aiming to enhance treatment efficacy and minimize side effects.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Trials in Dallas for neurological conditions include research on Alzheimer’s disease, Parkinson’s disease, multiple sclerosis (MS), and epilepsy. They may involve testing new pharmacological agents that target specific disease mechanisms, experimental treatments such as stem cell therapy or gene editing, and novel approaches like deep brain stimulation or cognitive rehabilitation programs.
The city’s research efforts are driven by the increasing prevalence of neurodegenerative disorders and the need for more effective treatments to manage these complex conditions.
Clinical trials in Dallas have a broad focus on managing diabetes and endocrine disorders, including type 1 and type 2 diabetes, metabolic syndrome, thyroid disorders, and polycystic ovary syndrome (PCOS).
Research often explores new insulin delivery systems, such as smart insulin pens and continuous glucose monitors, as well as innovative medications that address insulin resistance and hormonal imbalances. Trials also include studies on lifestyle interventions and weight management to improve long-term outcomes for individuals with diabetes and related conditions.
Many clinical trials in Dallas target autoimmune diseases like rheumatoid arthritis, lupus, and dermatological conditions such as psoriasis. Researchers are evaluating new biologic agents that specifically inhibit immune system components involved in these diseases, as well as combination therapies that aim to enhance efficacy and reduce the need for corticosteroids.
These trials also investigate novel approaches to manage symptoms and improve quality of life for patients with chronic autoimmune conditions.
Trials for respiratory conditions in Dallas include studies on asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. Research efforts focus on developing new inhaled medications, such as biologics that target specific inflammatory pathways in asthma, and advanced drug delivery systems that improve medication adherence and effectiveness.
Trials in infectious diseases cover a wide range of conditions, including HIV, hepatitis C, and influenza. Research includes the development of new antiviral medications, vaccines for emerging and re-emerging infections, and strategies for improving treatment adherence and outcomes. Trials may also investigate new diagnostic tools and treatment protocols to enhance disease management and prevention.
In Dallas, clinical trials are governed by a comprehensive framework that ensures ethical and regulatory compliance. Federal oversight is provided by the U.S. Food and Drug Administration (FDA), which sets standards for trial design, conduct, and reporting. All studies must be reviewed and approved by an Institutional Review Board (IRB), ensuring the protection of participant rights and adherence to ethical guidelines.
Researchers in Dallas are required to follow Good Clinical Practice (GCP) standards, which include strict protocols for data management, participant recruitment, and reporting adverse events. State-specific regulations from the Texas Medical Board also apply, alongside federal and privacy laws such as the Health Insurance Portability and Accountability Act (HIPAA), which safeguard participants' personal health information. The informed consent process is also crucial, providing participants with detailed information about the study and their rights.
Joining a clinical trial provides the exclusive benefit of accessing novel treatments and therapies before they become widely available. Participants also benefit from exceptional care by leading healthcare professionals, who provide thorough monitoring and customized support throughout the study.
Participating in clinical trials is essential for progressing medical research and may lead to groundbreaking advancements in treatments or preventative care. By volunteering in a trial, individuals not only gain early access to innovative medical solutions but also play a key role in advancing scientific knowledge, thereby contributing to future improvements in healthcare for others.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: